Analyst Price Target is $35.00
▲ +113.28% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Rapport Therapeutics in the last 3 months. The average price target is $35.00, with a high forecast of $35.00 and a low forecast of $35.00. The average price target represents a 113.28% upside from the last price of $16.41.
Current Consensus is
Buy
The current consensus among 3 contributing investment analysts is to buy stock in Rapport Therapeutics.